GR852573B - - Google Patents

Info

Publication number
GR852573B
GR852573B GR852573A GR850102573A GR852573B GR 852573 B GR852573 B GR 852573B GR 852573 A GR852573 A GR 852573A GR 850102573 A GR850102573 A GR 850102573A GR 852573 B GR852573 B GR 852573B
Authority
GR
Greece
Application number
GR852573A
Inventor
Helmut Dr Schickaneder
Rolf Dr Herter
Kurt Dr Wegner
Helmut Prof Dr Schunack
Istvan Dr Szelenyi
Stefan Dr Postius
Henning Dr Ahrens
Original Assignee
Heumann Ludwig & Co Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Ludwig & Co Gmbh filed Critical Heumann Ludwig & Co Gmbh
Publication of GR852573B publication Critical patent/GR852573B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR852573A 1985-04-12 1985-10-24 GR852573B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853513184 DE3513184A1 (de) 1985-04-12 1985-04-12 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
GR852573B true GR852573B (el) 1986-08-13

Family

ID=6267864

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852573A GR852573B (el) 1985-04-12 1985-10-24

Country Status (14)

Country Link
US (1) US4738960A (el)
EP (1) EP0197189A3 (el)
JP (1) JPS61238782A (el)
KR (1) KR860008172A (el)
AU (1) AU578766B2 (el)
DE (1) DE3513184A1 (el)
DK (1) DK501385A (el)
ES (1) ES8700245A1 (el)
GR (1) GR852573B (el)
HU (1) HU196064B (el)
IL (1) IL77097A0 (el)
NZ (1) NZ214231A (el)
PT (1) PT81409B (el)
ZA (1) ZA858841B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228941A1 (es) * 1978-04-26 1983-05-13 Glaxo Group Ltd Procedimiento para preparar nuevos derivados de 3,5-diamino-1,2,4-triazol que son activos contra receptores histaminicos
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
CA1275097A (en) * 1984-10-02 1990-10-09 Fujio Nohara Pyridyloxy derivatives
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118126A1 (de) * 1981-05-07 1982-12-02 Bayer Ag, 5090 Leverkusen Sulfenamide zur verwendung in arzneimitteln
US4600779A (en) * 1982-03-29 1986-07-15 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4578471A (en) * 1982-03-29 1986-03-25 Bristol-Myers Company Substituted amino alkyl pyridyl ethanediimidamides
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles
JPS59196879A (ja) * 1983-04-08 1984-11-08 Wakamoto Pharmaceut Co Ltd 新規な１，３，４−チアジアゾ−ル誘導体
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な１，３，４−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
DE3341750A1 (de) * 1983-11-18 1985-05-30 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,2,4-triazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
DE3441086A1 (de) * 1984-11-09 1986-05-15 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3,4-diazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DK501385D0 (da) 1985-10-31
HUT44525A (en) 1988-03-28
AU5024185A (en) 1986-10-16
KR860008172A (ko) 1986-11-12
DK501385A (da) 1986-10-13
ES8700245A1 (es) 1986-10-16
EP0197189A3 (de) 1987-05-27
DE3513184A1 (de) 1986-10-16
ZA858841B (en) 1986-07-30
PT81409B (de) 1987-04-13
JPS61238782A (ja) 1986-10-24
ES549378A0 (es) 1986-10-16
EP0197189A2 (de) 1986-10-15
NZ214231A (en) 1988-07-28
AU578766B2 (en) 1988-11-03
IL77097A0 (en) 1986-04-29
US4738960A (en) 1988-04-19
HU196064B (en) 1988-09-28
PT81409A (de) 1985-11-01

Similar Documents

Publication Publication Date Title
FR2580033B1 (el)
IN164139B (el)
FR2580096B1 (el)
IN164777B (el)
DE3688415T (el)
GB2175637B (el)
DE3590838T1 (el)
IN164296B (el)
GR852676B (el)
GR850641B (el)
GR850763B (el)
GR850873B (el)
GR851324B (el)
BA96126A (el)
IN162579B (el)
BG45210A1 (el)
BG45174A1 (el)
BG45495A1 (el)
BG45486A1 (el)
BG45483A1 (el)
BG45482A1 (el)
BG45480A1 (el)
BG45466A1 (el)
BG45438A1 (el)
BE902936A (el)